Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

BACKGROUND: Growth hormone (GH) treatment is currently recommended in Prader-Willi syndrome (PWS) patients. OBJECTIVES: To evaluate the impact (efficacy and safety) of the use of recombinant human GH (rhGH) as a treatment for PWS. METHOD: We performed a systematic review and, where possible, meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Passone, Caroline de Gouveia Buff, Franco, Ruth Rocha, Ito, Simone Sakura, Trindade, Evelinda, Polak, Michel, Damiani, Durval, Bernardo, Wanderley Marques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213882/
https://www.ncbi.nlm.nih.gov/pubmed/32411831
http://dx.doi.org/10.1136/bmjpo-2019-000630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213882/
https://www.ncbi.nlm.nih.gov/pubmed/32411831
http://dx.doi.org/10.1136/bmjpo-2019-000630

Ejemplares similares